Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance

摘要

Objective. In order to understand the patient's perspective in regards to meaningful surrogate clinical trial endpoints and the impact of treatment-related toxicity, and quality of life, we surveyed women with gynecological cancers to ascertain their preferences.